Episode

Relapsed/Refractory Chronic Lymphocytic Leukemia — A Grand Rounds Program

Podcast: Hematologic Oncology Update
Published: Sep 2, 2026
Duration seconds: 3520
Processing state: not_requested
Canonical source: https://hematologic-oncology.captivate.fm/episode/5666-gr2026-rrcll
Audio: https://dts.podtrac.com/redirect.mp3/episodes.captivate.fm/episode/09087108-940c-43e7-86da-46b29c247e07.mp3
JSON: /v1/public/podcasts/hematologic-oncology-update-916423/episodes/relapsed-refractory-chronic-lymphocytic-leukemia-a-grand-rounds-program
Markdown: /podcast/hematologic-oncology-update-916423/relapsed-refractory-chronic-lymphocytic-leukemia-a-grand-rounds-program.md

Actions

POST https://stenobird.com/v1/public/podcasts/hematologic-oncology-update-916423/episodes/relapsed-refractory-chronic-lymphocytic-leukemia-a-grand-rounds-program/transcription-requests
Idempotently request low-priority transcript generation for this episode.
GET https://stenobird.com/podcast/hematologic-oncology-update-916423/relapsed-refractory-chronic-lymphocytic-leukemia-a-grand-rounds-program.md
Read the agent-friendly Markdown representation of this episode resource.

Summary

Featuring perspectives from Dr William G Wierda, including the following topics: Introduction: Overview of the Grand Rounds Chronic Lymphocytic Leukemia Initiative (0:00) Sequencing Road Map (12:39) Key Datasets — Pirtobrutinib (21:08) Investigator Survey (34:09) Chimeric Antigen Receptor T-Cell Therapy (45:08) Other Novel Therapy Approaches (49:58) EHA 2026 (54:45) CME information and select publications